Royal Bank of Canada
DNA icon

Royal Bank of Canada’s Ginkgo Bioworks DNA Stock Holding History

Royal Bank of Canada’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Sell
142
-1,230
-90% -$10.2K ﹤0.01% 7247
2025
Q4 		$12K Sell
1,372
-51,762
-97% -$557K ﹤0.01% 6317
2025
Q3 		$774K Sell
53,134
-2,571
-5% -$30.8K ﹤0.01% 4174
2025
Q2 		$626K Buy
55,705
+55,468
+23,404% +$430K ﹤0.01% 4292
2025
Q1 		$1K Sell
237
-144
-38% -$1.47K ﹤0.01% 6647
2024
Q4 		$3K Sell
381
-336
-47% -$2.88K ﹤0.01% 6632
2024
Q3 		$6K Buy
717
+128
+22% +$1.28K ﹤0.01% 6454
2024
Q2 		$8K Sell
589
-844
-59% -$25.2K ﹤0.01% 6413
2024
Q1 		$66K Sell
1,433
-240
-14% -$12.4K ﹤0.01% 5409
2023
Q4 		$113K Buy
1,673
+54
+3% +$3.31K ﹤0.01% 5540
2023
Q3 		$116K Buy
1,619
+582
+56% +$46.5K ﹤0.01% 5285
2023
Q2 		$78K Buy
1,037
+493
+91% +$29.2K ﹤0.01% 5517
2023
Q1 		$29K Sell
544
-386
-42% -$24.5K ﹤0.01% 5882
2022
Q4 		$63K Sell
930
-380
-29% -$35K ﹤0.01% 5755
2022
Q3 		$163K Buy
1,310
+591
+82% +$70.4K ﹤0.01% 4938
2022
Q2 		$69K Buy
719
+283
+65% +$34.5K ﹤0.01% 5555
2022
Q1 		$70K Buy
436
+39
+10% +$7.59K ﹤0.01% 5867
2021
Q4 		$133K Buy
397
+260
+190% +$124K ﹤0.01% 5710
2021
Q3 		$63K Buy
+137
New +$66.7K ﹤0.01% 6018

Other funds holding DNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Royal Bank of Canada's DNA Position: Q1 2026 in Review

Royal Bank of Canada reduced its Ginkgo Bioworks (DNA) stake by 90% in Q1 2026, selling an estimated $10.2K and leaving 142 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7247.

Royal Bank of Canada first reported a position in DNA in Q3 2021 and has held it in 19 quarters since. The position peaked at $774K in Q3 2025. 174 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

  • Royal Bank of Canada held 142 shares of Ginkgo Bioworks worth $0 as of Q1 2026.
  • Royal Bank of Canada sold 1,230 Ginkgo Bioworks shares in Q1 2026, an estimated $10.2K.
  • Ginkgo Bioworks made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #7247 holding.
  • Royal Bank of Canada first reported a position in Ginkgo Bioworks in Q3 2021 and has held it in 19 quarters since.
  • Royal Bank of Canada's Ginkgo Bioworks position peaked at $774K in Q3 2025.
  • 174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.